Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
JAAD Case Rep ; 32: 29-31, 2023 Feb.
Article in English | MEDLINE | ID: covidwho-2243245
2.
Am J Dermatopathol ; 43(2): 144-145, 2021 Feb 01.
Article in English | MEDLINE | ID: covidwho-1263715

ABSTRACT

ABSTRACT: The varying cutaneous and pathological manifestations of coronavirus 2 (SARS-CoV-2 or COVID-19) may have prognostic implications. Acral ischemic findings present with a hypercoagulable state in critically ill COVID-19 patients. Pathologically confirmed varicella-like exanthem and perniosis COVID-19 cases have correlated with paucisymptomatic and asymptomatic patients in previous reports. We present the second case of biopsy-proven COVID-19 infection-induced chilblains (pernio) in a paucisymptomatic patient with a brisk perieccrine lymphocytic response. Based on an antecedent pathological study, we know coronavirus particles have been seen in the eccrine gland associated with a brisk peri-inflammatory response. The prominent perieccrine inflammation is helpful in the diagnosis of COVID-19 infections. Currently, nonischemic pathological findings correlate with a good prognosis based on the paucisymptomatic or asymptomatic nature of their disease courses. Patients presenting with suspected COVID-19 infection-induced chilblains who are paucisymptomatic or asymptomatic should be isolated and immediately tested with polymerase chain reaction (PCR) testing (as there is a delay in diagnosis based on the poor sensitivity of the current rapid test). We continue to stress the importance of early diagnosis and quarantining to prevent spread to the older and immunocompromised patients.


Subject(s)
COVID-19/virology , Chilblains/virology , SARS-CoV-2/pathogenicity , Skin/virology , Biopsy , COVID-19/complications , COVID-19/diagnosis , COVID-19/immunology , COVID-19 Testing , Chilblains/diagnosis , Chilblains/immunology , Early Diagnosis , Female , Host-Pathogen Interactions , Humans , Middle Aged , Skin/immunology , Skin/pathology
SELECTION OF CITATIONS
SEARCH DETAIL